A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people. A new preclinical model offers ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

A work group convened by the Alzheimer's Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer's disease (AD), including a new biomarker classification ...

A class of proteins that regulates cell repair and enhances cell growth-signaling systems could be a promising new target for the treatment of Alzheimer's and other neurodegenerative diseases, ...

A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people, according to a new study led by ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab bested placebo in ESSDAI score at 48 weeks among patients with Sjögren’s disease. Monthly ianalumab ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...